Amarantus BioScience Holdings, Inc. (AMBS)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 9, 2026
AMBS Market Cap
AMBS has a market cap or net worth of $630 as of October 16, 2026. It is the 52,488th most valuable company in the world and the 8,522nd biggest in the United States.
Market Cap
630.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,522 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 14, 2011, AMBS's market cap has decreased from 100.50M to 630.00, a decrease of -100.00%. That is a compound annual growth rate of -54.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 630.00 | - |
| Dec 30, 2025 | 630.00 | - |
| Dec 31, 2024 | 630.00 | -99.80% |
| Dec 29, 2023 | 315.20K | -68.01% |
| Dec 30, 2022 | 985.33K | -87.08% |
| Dec 31, 2021 | 7.63M | 165.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| American Oriental Bioengineering | 949.00 |
| eFFECTOR Therapeutics | 941.00 |
| Proteonomix | 791.00 |
| Pathfinder Cell Therapy | 667.00 |
| U.S. Stem Cell | 662.00 |
| Alzex Neuropharma | 602.00 |
| Adynxx | 581.00 |
| GlobeImmune | 575.00 |